Charles H.C.M. Buys
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 20
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 23
- Oncology top 1%
- Cancer-related Molecular Pathways 11
- Genetics top 1%
- Genomic variations and chromosomal abnormalities 21
- Molecular Biology top 2%
- RNA modifications and cancer 18
- Genomics and Chromatin Dynamics 11
- DNA Repair Mechanisms 10
-
- Cystic Fibrosis Research Advances 11
- Co-authors
- Robert M.W. HofstraJan OsingaAnke van den BergRudy M. LandsvaterHarry HollemaRein P. StulpKlaas KokYing Wu
- Journals
- Nature (2 papers)New England Journal of Medicine (2 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Charles H.C.M. Buys
152 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.3k
- Pathology and Forensic Medicine 1.5k
- Oncology 1.8k
- Genetics 1.5k
- Molecular Biology 3.2k
Countries citing papers authored by Charles H.C.M. Buys
This map shows the geographic impact of Charles H.C.M. Buys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles H.C.M. Buys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles H.C.M. Buys more than expected).
Fields of papers citing papers by Charles H.C.M. Buys
This network shows the impact of papers produced by Charles H.C.M. Buys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles H.C.M. Buys. The network helps show where Charles H.C.M. Buys may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles H.C.M. Buys, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 33 | |
| 2 | 2006 | 5 | |
| 3 | 2006 | 2 | |
| 4 | 2005 | 26 | |
| 5 | 2003 | 38 | |
| 6 | 2002 | 48 | |
| 7 | 2000 | 32 | |
| 8 | 2000 | 42 | |
| 9 | 2000 | 10 | |
| 10 | 1999 | 19 | |
| 11 | 1999 | 255 | |
| 12 | A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomabreakdown → | 1994 | 872 |
| 13 | 1993 | 8 | |
| 14 | 1992 | 1 | |
| 15 | 1992 | 6 | |
| 16 | 1992 | 16 | |
| 17 | 1991 | 17 | |
| 18 | 1989 | 13 | |
| 19 | 1989 | 2 | |
| 20 | 1988 | 33 |
About Charles H.C.M. Buys
Charles H.C.M. Buys is a scholar working on Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 155 papers that have together received 7.0k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (23 papers), Genomic variations and chromosomal abnormalities (21 papers), Cancer Genomics and Diagnostics (20 papers), RNA modifications and cancer (18 papers), Cystic Fibrosis Research Advances (11 papers), Cancer-related Molecular Pathways (11 papers), Genomics and Chromatin Dynamics (11 papers) and DNA Repair Mechanisms (10 papers). The work is most often cited by research in Cancer Research (1.3k citations), Pathology and Forensic Medicine (1.5k citations) and Oncology (1.8k citations). Charles H.C.M. Buys has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Robert M.W. Hofstra, Jan Osinga, Anke van den Berg, Rudy M. Landsvater, Harry Hollema, Rein P. Stulp, Klaas Kok, Ying Wu, Hans Scheffer and Jan H. Kleibeuker. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.